Intec Pharma Ltd.

Nov 01, 2017

Intec Pharma Ltd. Announces Changes to its Board of Directors

Nov 01, 2017

Intec Pharma, Ltd. Announces Changes to its Board of Directors

Oct 26, 2017

Intec Pharma Names Walt Linscott as Chief Administrative Officer

Oct 06, 2017

Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit

Sep 20, 2017

Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference

Sep 08, 2017

Intec Pharma to Participate in the 19th Annual Rodman & Renshaw Global Investment Conference

Sep 01, 2017

Intec Pharma to Participate in BioCentury's 24th Annual NewsMakers in the Biotech Industry Conference

Aug 21, 2017

Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares

Aug 16, 2017

Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares

Aug 15, 2017

Intec Pharma Announces Proposed Public Offering of Ordinary Shares

Aug 09, 2017

Intec Pharma Reports Financial Results for the First Six Months of 2017

Aug 03, 2017

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

Jul 27, 2017

Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer

Jul 19, 2017

Intec Pharma Granted Patent in Hong Kong for Accordion Pill(TM) Carbidopa / Levodopa